Royalty Pharma Q3 Adj. EPS $1.17 Beats $1.04 Estimate, Sales $609.000M Miss $739.257M Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsEarnings MissesNews
Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $1.04 by 12.18 percent. This is a 12.5 percent increase over earnings of $1.04 per share from the
Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $1.04 by 12.18 percent. This is a 12.5 percent increase over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $609.000 million which missed the analyst consensus estimate of $739.257 million by 17.62 percent. This is a 7.79 percent increase over sales of $565.000 million the same period last year.